Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 2, 2017, to report its financial results for the fourth quarter and full year ended December 31, 2016. The accompanying press release (Exhibit 99.1) contains the detailed financial performance for the period. Investors should review this press release for specific revenue, profit, and divisional performance metrics. While the 8-K itself is brief and primarily serves to furnish the press release, the press release is the critical document for understanding the company's recent financial condition and operational results. This filing is a standard procedure for publicly traded companies to disseminate timely financial information to the market.
Key Highlights
- 1Boston Scientific reported its Q4 and full-year 2016 financial results on February 2, 2017.
- 2The filing's primary purpose is to furnish the press release detailing these financial results.
- 3Investors should refer to Exhibit 99.1 (the press release) for specific financial performance data.
- 4The 8-K itself does not contain the financial results but directs investors to the press release.
- 5The information is furnished, not filed, under Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities for inaccuracies.
- 6This filing is a routine disclosure for publicly traded companies to announce earnings.